Literature DB >> 11160445

Behavioral activation in rats requires endogenous ascorbate release in striatum.

G V Rebec1, Z Wang.   

Abstract

Ascorbate (vitamin C) is found in high concentrations in the striatum in which it may play a role in behavioral activation. To test this hypothesis, freely behaving rats received bilateral intrastriatal infusions of ascorbate oxidase (AAO) to inactivate extracellular ascorbate. Slow-scan voltammetry was used simultaneously to assess changes in ascorbate and 3,4-dihydroxyphenylacetic acid (DOPAC), a major dopamine metabolite, near the infusion site. Intrastriatal AAO, but not saline vehicle, caused a rapid decline in both ascorbate and behavioral activation. Within 20 min, an ascorbate loss of 50-70% led to a near-total inhibition of all recorded behavior, including open-field locomotion, approach of novel objects, and social interactions with other rats. DOPAC levels remained stable, arguing against an AAO-induced disruption of dopamine transmission. Consistent with this interpretation, subsequent injection of 1.0 mg/kg d-amphetamine, an indirect dopamine agonist, quickly restored behavioral activation, which also was accompanied by a marked rise in extracellular ascorbate. Bilateral AAO infusions into dorsal hippocampus, which also has a high level of extracellular ascorbate, failed to alter behavioral activation, indicating that a loss of brain ascorbate per se does not suppress behavior. Collectively, these results implicate ascorbate in the behavioral operations of the striatum and suggest that the extracellular level of this vitamin plays a critical role in behavioral activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160445      PMCID: PMC6763817     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  67 in total

Review 1.  The neostriatum beyond the motor function: experimental and clinical evidence.

Authors:  P Calabresi; M De Murtas; G Bernardi
Journal:  Neuroscience       Date:  1997-05       Impact factor: 3.590

2.  Effects of ascorbate in microdialysis perfusion medium on the extracellular basal concentration of glutamate in rat's striatum.

Authors:  Y J Lai; E Y Shen; W H Pan
Journal:  Neurosci Lett       Date:  2000-02-04       Impact factor: 3.046

Review 3.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

4.  Release of endogenous ascorbic acid preserves extracellular dopamine in the mammalian retina.

Authors:  M J Neal; J R Cunningham; K L Matthews
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-11       Impact factor: 4.799

5.  Dynamic changes in extracellular fluid ascorbic acid monitored by in vivo electrochemistry.

Authors:  B Ghasemzadeh; J Cammack; R N Adams; B Ghasemzedah
Journal:  Brain Res       Date:  1991-04-26       Impact factor: 3.252

6.  Regional distribution of ascorbate and 3,4-dihydroxyphenylacetic acid (DOPAC) in rat striatum.

Authors:  A Basse-Tomusk; G V Rebec
Journal:  Brain Res       Date:  1991-01-04       Impact factor: 3.252

Review 7.  A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission.

Authors:  G V Rebec; R C Pierce
Journal:  Prog Neurobiol       Date:  1994-08       Impact factor: 11.685

Review 8.  Involvement of basal ganglia transmitter systems in movement initiation.

Authors:  W Hauber
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

9.  Effect of bilateral 6-OHDA lesions of the substantia nigra on locomotor activity in the rat.

Authors:  K Sakai; D M Gash
Journal:  Brain Res       Date:  1994-01-07       Impact factor: 3.252

10.  Effect of D-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats.

Authors:  J F Nash; B K Yamamoto
Journal:  Brain Res       Date:  1993-11-05       Impact factor: 3.252

View more
  12 in total

Review 1.  Corticostriatal network dysfunction in Huntington's disease: Deficits in neural processing, glutamate transport, and ascorbate release.

Authors:  George V Rebec
Journal:  CNS Neurosci Ther       Date:  2018-02-21       Impact factor: 5.243

2.  Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice.

Authors:  M Lazzarini; C Salum; E A Del Bel
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

3.  Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease.

Authors:  Jenelle L Dorner; Benjamin R Miller; Scott J Barton; Tyler J Brock; George V Rebec
Journal:  Behav Brain Res       Date:  2007-01-18       Impact factor: 3.332

Review 4.  Carbon Anode in Carbon History.

Authors:  César A C Sequeira
Journal:  Molecules       Date:  2020-10-28       Impact factor: 4.411

5.  Nociceptive behavioral responses to chemical, thermal and mechanical stimulation after unilateral, intrastriatal administration of 6-hydroxydopamine.

Authors:  Eric H Chudler; Ying Lu
Journal:  Brain Res       Date:  2008-04-08       Impact factor: 3.252

6.  Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of Huntington's disease.

Authors:  Jenelle L Dorner; Benjamin R Miller; Emma L Klein; Alexander Murphy-Nakhnikian; Rachel L Andrews; Scott J Barton; George V Rebec
Journal:  Brain Res       Date:  2009-07-16       Impact factor: 3.252

Review 7.  Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability.

Authors:  Balázs Pál
Journal:  Cell Mol Life Sci       Date:  2018-05-15       Impact factor: 9.261

8.  Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease.

Authors:  Benjamin R Miller; Jenelle L Dorner; Kendra D Bunner; Thomas W Gaither; Emma L Klein; Scott J Barton; George V Rebec
Journal:  J Neurochem       Date:  2012-03-28       Impact factor: 5.372

9.  Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington's disease.

Authors:  George V Rebec
Journal:  Antioxid Redox Signal       Date:  2013-06-19       Impact factor: 8.401

10.  Extracellular ascorbate modulates glutamate dynamics: role of behavioral activation.

Authors:  Michael I Sandstrom; George V Rebec
Journal:  BMC Neurosci       Date:  2007-05-16       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.